Mice receiving Ccl5-deficient BM exhibited reduced albuminuria, less glomerulosclerosis, and higher WT-1+ podocyte counts, regardless of host genotype, suggesting that BM-derived CCL5 drives injury. This evidence concerns the gene WT1 and glomerulosclerosis.